REFERENCES
- Albaladejo RG, Aparicio S. Variation patterns in the Phlomis composite (Lamiaceae) hybrid complex in Iberian peninsula. Bot J Linn Soc 2004; 145:97–108.
- Kyriakopoulo I, Magiatis P, Skaltounis AI, Aligiannis N, Samioside HC. A new phenylethanoid glycoside with free-radical scavenging and antimicrobial activities from Phlomis samia. J Nat Prod 2001; 64:1095–1097.
- Calis I. Kırmızıbekmez H. Glycoside from Phlomis lunariifolia. Phytochemistry 2004; 65:2619–2625.
- Sarkhail P, Hamid RME, Gholam RA, Mohammad HSS, Abass S. Phytochemical study of Phlomis olivieri Benth. and Phlomis persica Boiss. DARU J Pharm Sci 2006; 14:115–121.
- Kamel MS, Mohamed KM, Hassanean HA, . Iridoid and megastigmane glycosides from Phlomis aurea. Phytochemistry 2001; 55:353–357.
- Hussain J, Riaz-ullah KA, Mabood F, . Antispasmodic and Ca++ antagonist potential of marrubiin, a labdane type diterpene from Phlomis bracteosa. J Pharm Res 2011; 4:178–180.
- Hussain J, Riaz-ullah KA, Khan F, Mohammad Z, Shah MR. Phlomeoic acid: A new diterpene from Phlomis bracteosa. Nat Prod Commun 2011; 6: 171–173.
- Williamson EM, Okpako DT, Evans FJ. Selection, Preparation and Pharmacological Evaluation of Plant Material. Chichester, UK: John Wiley & Sons, 1998, 15–23.
- National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press, 1996, 1–7.
- Khan A, Gilani AH. Cardiovascular inhibitory effects of Hyoscyamus niger. Methods Fin Exp Clin Pharmacol 2008; 30:295–300.
- Khan A, Gilani AH. Pharmacodynamic evaluation of Terminalia bellerica for its antihypertensive effect. J Food Drug Anal 2008; 16:6–14.
- Karaki H, Ozaki H, Hori M, . Calcium movements, distribution and functions in smooth muscle. Pharmacol Rev 1997; 49:157–230.
- Godfraind T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev 1986; 38:321–416.
- Wang GJ, Shum AY, Lin YL, . Calcium channel blockade in vascular smooth muscle cells: major hypotensive mechanism of S-petasin, a hypotensive sesquiterpene from Petasites formosanus. J Pharmacol Exp Ther 2001; 297:240–246.
- Vanhoutte PM, Rubanyi GM, Miller VM, Houston DS. Modulation of vascular smooth muscle contraction by endothelium. Ann Rev Physiol 1986; 48:307–330.
- Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 299:373–376.
- Johansen PL Hemodynamic effects of calcium antagonists in hypertension. In: Epstein M, Ed. Calcium Antagonists in Clinical Medicine. Philadelphia, PA: Hanley and Belfus, 1992, 69–88.
- Ajay M, Gilani AH, Mustafa MR. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci 2003; 74:603–612.
- Ghayur MN, Gilani AH. Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. J Cardiovasc Pharmacol 2005; 45:74–80.
- Ghayur MN, Gilani AH, Afridi MB, Houghton PJ. Cardiovascular effects of Ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vascular Pharmacol 2005; 43:234–241.
- Musha S, Watanabe M, Ishida Y, . A phenoxazine compound, 2-amino-4,4α-dihydro-4α-7-dimethyl-3H-phenoxazine-3-one reverses the phenylephrine or high-K+ induced contractions of smooth muscles in rat aorta and guinea-pig tenia cecum. Biol Pharm Bull 2005; 28:1521–1523.
- Cauvin C, Malik S. Induction of calcium influx and calcium release in isolated rat aorta and mesenteric resistance vessels by norepinephrine activation of α-receptors. J Pharmacol Exp Ther 1984; 230:413–418.
- Okmura K, Ichihara K, Nagaska M, Oda N, Tajima K. Calcium entry blocking activities of MPC-1304 and of its enantiomers and metabolites. Eur J Pharmacol 1993; 235:69–74.
- Chan SS, Choi AO, Jones RL, Lin G. Mechanisms underlying the vasorelaxing effects of butylidenephthalide, an active constituent of Ligusticum chuanxiong in rat isolated aorta. Eur J Pharmacol 2006; 537:111–117.
- Andreopouos S, Papapetropoulos A. Molecular aspects of soluble guanyl cyclase regulation. Gen Pharmacol 2000; 34:147–157.
- Thorin E, Huang PL, Fishman MC, Bevan JA. Nitric oxide inhibits alpha2-adrenoceptor-mediated endothelium-dependent vasodilation. Circ Res 1998; 82:1323–1329.